BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Arena Pharmaceuticals, Inc. Announces Positive Phase 2a Clinical Trial Results of APD125 to Treat Insomnia

  June 12, 2008

   · 

  8 min read
• Pharm Country

  MonoSolRx LLC Closes $10 Million in Private Debt Financing

  June 12, 2008

   · 

  2 min read
• Drug Development

  ChemoCentryx, Inc. Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohn’s Disease

  June 12, 2008

   · 

  9 min read
• Drug Development

  Incyte Corporation’s JAK Inhibitor Demonstrates Marked Clinical Benefits in Phase IIa Rheumatoid Arthritis Study

  June 12, 2008

   · 

  1 min read
• Drug Development

  Pharmaxis Ltd Long-Term Safety Study of Bronchitol Completes

  June 12, 2008

   · 

  2 min read
• Drug Development

  Repligen Corporation Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder

  June 12, 2008

   · 

  7 min read
• American Scientific Resources Inc. Updates and Clarifies Capital Structure Disclosure

  June 12, 2008

   · 

  1 min read
• Drug Development

  Chemokine Therapeutics Corp. Announces Final Results of CTCE-9908 Phase I/II Clinical Trial in Late Stage Cancer Patients

  June 12, 2008

   · 

  1 min read
• BioCapital

  PharmAthene, Inc. CEO Participates on Panel at the 6th Annual Biodefense Vaccines & Therapeutics Conference in Washington DC

  June 12, 2008

   · 

  4 min read
• American Scientific Resources Inc. Clarifies Capital Structure, Disclosure

  June 12, 2008

   · 

  1 min read